EBITDA multiples, deal structures, and the key factors that determine price in medical aesthetics acquisitions — from independent practices to PE roll-up targets.
Find Med Spa Businesses For SaleMed spas are valued primarily on a multiple of Seller's Discretionary Earnings (SDE) or EBITDA, with the applicable range driven by revenue quality, provider dependency, and the predictability of recurring revenue through memberships and packages. Businesses with systems-driven operations, diversified service menus, and 200+ active recurring members command premiums at or above the midpoint of the range, while owner-operator-dependent practices with concentrated revenue trade at meaningful discounts. Acquirers — including PE-backed roll-up platforms and entrepreneurial operators using SBA financing — apply heightened scrutiny to deferred revenue liabilities, corporate practice of medicine compliance, and equipment capitalization before arriving at a final offer price.
3.5×
Low EBITDA Multiple
4.75×
Mid EBITDA Multiple
6×
High EBITDA Multiple
Independent med spas generating $300K–$500K in EBITDA with clean financials and a licensed medical director typically trade between 3.5x and 5x EBITDA. Practices with 200+ active membership subscribers, an employed provider team (not owner-injector dependent), diversified revenue across injectables, laser, and body contouring, and a dominant local brand in a high-income market can achieve 5x–6x or above. Practices where the owner is the primary injector, revenue is declining, or deferred package liabilities are significant typically price at 3.5x or below — if they can be sold at all without significant deal restructuring.
$2,200,000
Revenue
$480,000
EBITDA
4.75x
Multiple
$2,280,000
Price
SBA 7(a) loan covering $1,824,000 (80%) at current SBA rates over 10 years; buyer equity injection of $228,000 (10%); seller note of $228,000 (10%) at 6% interest over 5 years, on standby for 24 months. Deal structured as an asset purchase with a management services agreement (MSA) to separate the medical entity for CPOM compliance. Medical director agreement transferred to new ownership entity at close. Six-month seller transition included at no additional cost to support patient and staff retention.
EBITDA Multiple (Primary Method)
The most widely used valuation method for med spas with $300K+ in annual EBITDA. Normalized EBITDA — adjusted for owner compensation, personal expenses run through the business, and one-time costs — is multiplied by a market-derived multiple ranging from 3.5x to 6x depending on business quality, provider structure, and revenue predictability. PE-backed buyers and SBA-financed transactions both anchor to this method.
Best for: Profitable med spas with $300K+ EBITDA, employed provider teams, and clean financial records suitable for institutional or SBA-financed acquisition
Seller's Discretionary Earnings (SDE) Multiple
For smaller owner-operated med spas below $500K in revenue, SDE — which adds back the owner's total compensation and benefits on top of EBITDA — is the more practical valuation benchmark. SDE multiples for med spas typically range from 2.5x to 4x depending on size, location, and transferability of client relationships. This method is most relevant when a buyer is replacing the owner operationally and needs to understand total economic benefit.
Best for: Solo-practitioner or small owner-operator med spas where the owner performs injections and the buyer needs to assess full economic benefit before accounting for replacement labor
Revenue Multiple (Secondary / Sanity Check)
Med spa transactions are occasionally discussed using revenue multiples — typically 0.75x to 1.5x annual revenue — as a secondary benchmark, particularly when EBITDA margins are compressed or when a buyer is acquiring primarily for the patient database, brand, and location. This method is less reliable and most useful as a high-level sanity check against EBITDA-based pricing, not as the primary driver of deal value.
Best for: Distressed or low-margin practices where EBITDA multiples produce an impractical number, or when a strategic acquirer is pricing in synergies from integrating an existing patient base into a larger platform
Active Membership Program with 200+ Subscribers
A robust membership program generating predictable monthly recurring revenue is the single most powerful value driver in a med spa sale. Buyers — especially PE roll-up platforms — price membership revenue at a premium because it reduces customer acquisition cost, improves cash flow predictability, and signals brand loyalty. A practice with 300+ active members on a $150–$200/month program can add 0.5x–1x to the EBITDA multiple compared to a transactional-only competitor.
Owner Not Performing Injections — Systems-Driven Operations
Practices where the owner has successfully hired and retained a team of employed injectors, aestheticians, and a licensed medical director — and stepped back from clinical duties — are dramatically more transferable and command the highest multiples. Buyers pay a premium for businesses that run without the seller, because transition risk is low and the revenue base is tied to the brand and team rather than one individual's relationships.
Diversified Service Revenue Across Multiple Treatment Categories
Med spas generating revenue across injectables (Botox, fillers), laser and energy-based treatments, body contouring, and medical-grade skincare retail are significantly more valuable than single-service practices. Diversification reduces the impact of any one treatment trend declining, protects against device obsolescence, and signals a mature, well-rounded clinical operation that can grow with a new owner.
Patient Database with Documented Retention and Spend Metrics
A proprietary database of 1,000+ active patients with documented average annual spend, visit frequency, and reactivation rates is a tangible, transferable asset buyers will pay for. Practices that can demonstrate a 60%+ annual patient retention rate and a $500+ average annual spend per active client provide acquirers with the data confidence needed to underwrite a premium multiple.
Prime Location in a High-Income Demographic Market
Real estate and market positioning matter significantly in med spa acquisitions. Practices located in affluent suburban corridors, high-traffic medical or retail centers in zip codes with median household incomes above $90,000 command location premiums. Strong Google reviews (4.7+ stars, 300+ reviews), local brand dominance, and long-term lease security in a proven market all contribute to defensible competitive positioning that buyers reward at closing.
Clean Compliance History and Transferable Medical Director Agreement
Buyers — and their lenders — require a clean regulatory track record. A current, transferable medical director agreement, no outstanding malpractice claims, and a documented history of operating within state corporate practice of medicine (CPOM) guidelines significantly accelerates due diligence and reduces deal risk. This is often the difference between a deal closing at full value and a buyer re-trading the price after diligence.
Owner Is the Primary or Sole Injector
If the seller performs the majority of injections and holds the core patient relationships personally, buyers will apply steep discounts — or walk away. This key-person dependency creates severe transition risk: when the owner leaves, the revenue may follow. Buyers financing with SBA loans face additional hurdles because lenders require demonstrated business continuity without the seller. Practices in this situation often trade at 2x–3x EBITDA at best, or require extended earnout structures to bridge the gap.
Revenue Declining Year-Over-Year
Declining revenue — whether caused by new local competition, provider turnover, outdated laser and device equipment, or loss of a key injector — is the fastest way to suppress a valuation. Buyers extrapolate negative trends forward and will either reduce the multiple significantly, require a heavy seller note with contingent paydown, or pass entirely. Sellers experiencing revenue pressure should stabilize the business for 12–18 months before going to market.
Large Deferred Revenue Liability from Pre-Sold Packages and Memberships
Unearned revenue from pre-sold treatment packages or membership credits sitting on the balance sheet is a direct reduction in net proceeds. Buyers must honor these obligations post-close without receiving the corresponding cash, which effectively reduces the purchase price they are willing to pay. Sellers should audit and reconcile all outstanding package balances prior to going to market and avoid aggressive pre-selling in the 12 months leading up to a transaction.
Corporate Practice of Medicine Compliance Issues or Regulatory History
State CPOM laws prohibit non-physicians from owning the medical component of a healthcare practice in many states. Practices that are not properly structured — missing a valid medical director agreement, operating without appropriate physician oversight, or co-mingling the medical and management entities improperly — face deal-killing compliance risk. Any prior regulatory actions, board complaints, or unresolved malpractice claims will either kill a deal or force significant price reductions and indemnification escrows.
Poor Financial Documentation and Commingled Personal Expenses
Med spa sellers who cannot produce three years of clean, accrual-based financial statements with clearly documented add-backs will lose buyer confidence and lender approval. Cash revenue not reported, personal vehicle payments, family member payroll, and inconsistent bookkeeping make it impossible for a buyer's accountant or SBA lender to underwrite a reliable EBITDA figure — which directly suppresses the multiple and deal price.
Heavy Equipment Depreciation and Upcoming Capital Expenditure Requirements
Laser platforms, body contouring devices, and energy-based treatment systems depreciate rapidly and require costly upgrades every 5–7 years. Buyers conducting equipment diligence will discount the purchase price for devices that are nearing end of useful life, under lease agreements with unfavorable buyout terms, or technologically obsolete relative to competitive practices in the market. Sellers should provide complete equipment inventory with purchase dates, lease terms, maintenance records, and estimated replacement costs.
Find Med Spa Businesses For Sale
Signal-scored targets with seller motivation, multiples, and outreach — free to join.
Most profitable med spas in the lower middle market sell for 3.5x to 6x EBITDA, with the midpoint around 4.5x–5x for well-run practices. The multiple is heavily influenced by whether the owner is performing injections, how strong the membership program is, and how clean the compliance and financial records are. PE-backed roll-up buyers may pay at or above the top of the range for practices that fit their platform criteria and geography.
Yes, med spas are generally SBA 7(a) eligible when structured correctly. The key requirements include a licensed medical director in place, clean compliance history, and at least $300K in normalized EBITDA to support debt service. Buyers typically inject 10–20% equity and may pair SBA financing with a seller note. The deal must be structured as an asset purchase or through a management services agreement to comply with state corporate practice of medicine laws — your SBA lender and attorney need to coordinate on this early in the process.
CPOM laws in many states prohibit non-physician entities from owning the medical component of a practice. In a med spa acquisition, this typically means the deal must be structured with a separate physician-owned medical entity (the PC or PLLC that employs the medical director) and a management services company (owned by the buyer) that contracts with the medical entity for business services. This MSA structure is standard in the industry but requires experienced healthcare M&A legal counsel to execute correctly. Buyers who ignore CPOM compliance risk regulatory action post-close.
Owner-injector dependency is the single biggest value killer in med spa transactions. When the seller is the primary or sole provider of injectable treatments, the revenue is personally tied to them — not to the business. Buyers apply steep discounts (sometimes 1x–2x EBITDA) or require large earnouts because they cannot be confident the patients will stay after the owner exits. Sellers who want maximum value should hire and retain an employed injector team at least 12–24 months before going to market.
Membership programs are a significant positive value driver, but they also create a deferred revenue liability that buyers must account for. Active members paying monthly fees signal predictable, recurring revenue — which buyers pay premium multiples for. However, any pre-paid credits or unused membership benefits outstanding at close represent obligations the buyer must honor without receiving new cash. Sellers should provide a clean reconciliation of all outstanding membership obligations, and both parties should negotiate how these liabilities are handled at close — typically through a price adjustment or escrow holdback.
The typical timeline to sell a med spa from initial preparation to closing is 12–18 months. This includes 3–6 months of pre-market preparation (cleaning up financials, resolving compliance issues, documenting provider agreements), 3–6 months of active marketing and buyer diligence, and 60–90 days for legal documentation, SBA loan processing, and closing. Practices with clean records, employed provider teams, and organized documentation can compress this timeline. Practices with complex compliance issues or poor financials will take longer or may not close at full value.
Private equity-backed aesthetics roll-up platforms are specifically looking for med spas with a minimum $300K–$500K in EBITDA, a patient database of 1,000+ active clients, an active membership program, a licensed medical director who is not the owner, and a location in a high-income or high-growth suburban market. They prioritize practices that are systems-driven and scalable — not dependent on one provider's relationships. In addition to price, PE buyers typically offer management rollover equity (15–25%) and earnout structures tied to EBITDA growth, which can significantly increase total seller proceeds if the business continues to grow post-acquisition.
More Med Spa Guides
DealFlow OS surfaces acquisition targets, scores seller motivation, and generates outreach — free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers